CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $)	Jun. 30, 2014	Mar. 31, 2014
Current assets
Cash	$ 807,330	$ 1,250,279
Accounts receivable	11,096	95,177
Deferred financing costs	77,749	83,191
Prepaid expenses and other current assets	41,855	50,699
Total current assets	938,030	1,479,346
Property and equipment, net	77,232	84,279
Patents and patents pending, net	110,198	112,489
Deposits	18,988	18,988
Total assets	1,144,448	1,695,102
Current Liabilities
Accounts payable	658,185	517,651
Due to related parties	818,070	839,070
Notes payable	390,000	390,000
Convertible notes payable, net of discounts	482,655	1,367,655
Derivative liabilities	0	10,679,067
Other current liabilities	1,314,943	1,855,374
Total current liabilities	3,663,853	15,648,817
Noncurrent liabilities
Convertible notes payable, noncurrent portion	1,001,451	776,451
Total noncurrent liabilities	1,001,451	776,451
Total liabilities	4,665,304	16,425,268
Commitments and Contingencies
Stockholders' Deficit
Common stock, par value $0.001 per share; 500,000,000 shares authorized as of June 30, 2014 and March 31, 2014; 253,395,651 and 224,973,980 shares issued and outstanding as of June 30, 2014 and March 31, 2014, respectively	253,394	224,984
Additional paid-in capital	74,544,327	59,659,137
Accumulated deficit	(78,488,496)	(74,832,557)
Total Aethlon Medical, Inc. stockholders’ deficit before noncontrolling interests	(3,690,775)	(14,948,436)
Noncontrolling interests	169,919	218,270
Total deficit	(3,520,856)	(14,730,166)
Total liabilities and deficit	$ 1,144,448	$ 1,695,102